- Report
- January 2021
- 146 Pages
China, Global
From €3000EUR$3,324USD£2,667GBP
Cefditoren is a cephalosporin antibiotic used to treat a variety of bacterial infections. It is a third-generation cephalosporin, which means it is more effective against certain bacteria than first- and second-generation cephalosporins. Cefditoren is used to treat infections of the respiratory tract, skin, and urinary tract, as well as some sexually transmitted diseases. It is also used to prevent infections in people who are undergoing certain medical procedures. Cefditoren is available in both oral and injectable forms.
The cefditoren market is a growing segment of the global antibiotics market. It is expected to benefit from the increasing prevalence of bacterial infections, the rising demand for antibiotics, and the growing awareness of the importance of antibiotic stewardship. The market is also expected to benefit from the development of novel cefditoren formulations and the increasing availability of generic cefditoren products.
Some of the major companies in the cefditoren market include Pfizer, Merck, Sanofi, GlaxoSmithKline, Novartis, and AstraZeneca. Show Less Read more